Nuzenio

Tradingview Amylyx Pharmaceuticals

Tradingview Amylyx Pharmaceuticals entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Amylyx Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $26.7, Implies 22% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:04 GMTAmylyx Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 15:04:22 GMTAmylyx Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:02:42 GMTAmylyx Pharmaceuticals Q2 posts higher than expected loss - TradingViewTradingView · Thu, 06 Aug 2026 11:26:41 GMTAmylyx Pharmaceuticals, Inc. 2Q 2026: Net loss $43.4M, EPS $(0.39) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:11:00 GMTAmylyx Pharmaceuticals reports Q2 net loss $43.4M, cash $250.8M, runway into 2028 - TradingViewTradingView · Thu, 06 Aug 2026 11:03:01 GMTAmylyx Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $25.56, Implies 26% Upside - TradingViewTradingView · Mon, 03 Aug 2026 23:20:03 GMT

Timeline

Thu, 06 Aug 2026 23:20:04 GMTAmylyx Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $26.7, Implies 22% Upside - TradingView
Thu, 06 Aug 2026 15:04:22 GMTAmylyx Pharmaceuticals Q2 Earnings Call Highlights - TradingView
Thu, 06 Aug 2026 13:02:42 GMTAmylyx Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 11:26:41 GMTAmylyx Pharmaceuticals Q2 posts higher than expected loss - TradingView
Thu, 06 Aug 2026 11:11:00 GMTAmylyx Pharmaceuticals, Inc. 2Q 2026: Net loss $43.4M, EPS $(0.39) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 11:03:01 GMTAmylyx Pharmaceuticals reports Q2 net loss $43.4M, cash $250.8M, runway into 2028 - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Amylyx Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.